ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676858 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676858; 2) Community: the network communities that were significantly associated with the response to NSC 676858; 3) Molecule: the relationships between components within communities and NSC 676858; 4) MDR: the compounds that were significantly associated with the NSC 676858.

NSC Compound Enrichment Correlation
NSC 625624 7,12-Epidioxybenz[a]anthracene, 7,12-dihydro-7-methyl- 0.0048681766467277 0.51068676
NSC 632573 Tris(1,3-diphenylpropane-1,3-dionata)gallium(III) 0.0048681766467277 0.30153692
NSC 637209 Dichlorobis[1-(4-nitrophenyl)-3-phenylpropane-1,3-dionato]-titanium(IV) 0.0048681766467277 0.17400551
NSC 683405 Null 0.00486817664672774 0.34993556
NSC 704171 Null 0.00486817664672774 0.43789384
NSC 708048 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, ethyl ester, (2Z,1E)- 0.00486817664672774 0.56327921
NSC 709362 Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- 0.00486817664672774 0.511263
NSC 714636 Null 0.00486817664672774 0.15021884
NSC 718729 Cyclopent-4-ene-1,3-dione, 2-[[4-hydroxy-3,5-bis(1,1-dimethylethyl)phenyl]methyl]- 0.00486817664672774 0.42650513
NSC 726146 Null 0.00486817664672774 0.41565932
Total:101  Current:17    [First] [Prev] [Next] [Last]